NEA leads funding round for Advanced Cardiac Therapeutics
Medical device company Advanced Cardiac Therapeutics has raised an undisclosed amount of funding in a round led by New Enterprise Associates. Previous backer NBGI Ventures was also an investor. In conjunction with the funding, ACT has added Justin Klein, a partner at NEA, to its board of directors. Also, Ajax Vascular CEO has been named chairman of the board while VytronUS CEO Mike Pederson joins the board as an independent director.
21 April 2014•4 mins read
